Clinical Trial

Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 4, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
Americans continue to consume high amounts of sodium. Potassium is notable for its blood pressure lowering effects but less is known regarding its effect on the vasculature. This investigation seeks to determine the role of dietary potassium on the vasculature in the presence of a high sodium diet in salt-resistant adults.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2019-09-23; most recent amendment 2026-03-02.
Trial Details
NCT Number NCT04101188
Lead Sponsor University of Delaware
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Cardiovascular Risk Factor
Enrollment 90 participants
Start Date 2020-01-16
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-04